Showing results (21-30 of 27) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|July 20, 2007
Monocyte chemoattractant protein-1 or macrophage inflammatory protein-1alpha deficiency does not affect angiotensin II-induced intimal hyperplasia in carotid artery ligation modelLe-Ning Zhang, Valdeci da Cunha, Baby Martin-McNulty, et al.Arthritis Research & Therapy|November 27, 2007
Gait analysis in a murine model of collagen-induced arthritisJon Vincelette, Yifan Xu, Le-Ning Zhang, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|August 12, 2009
Inhibition of soluble epoxide hydrolase attenuated atherosclerosis, abdominal aortic aneurysm formation, and dyslipidemiaLe-Ning Zhang, Jon Vincelette, Ying Cheng, et al.Oncology Letters|December 7, 2019
The inhibitory effects of cisplatin-radiation combination treatment on malignant osteosarcoma MG-63 cells and BRCA1-p53 pathways are more efficient than single treatmentsHong-Bin Sun, He-Yuan Wang, Bing Wu, et al.Journal of Applied Physiology (Bethesda, Md. : 1985)|June 10, 2003
Effectiveness of intermittent -Gx gravitation in preventing deconditioning due to simulated microgravityLi-Fan Zhang, Biao Sun, Xin-Sheng Cao, et al.European Journal of Pharmacology|December 29, 2010
Inhibition of soluble epoxide hydrolase attenuates endothelial dysfunction in animal models of diabetes, obesity and hypertensionLe-Ning Zhang, Jon Vincelette, Dawn Chen, et al.Bioorganic & Medicinal Chemistry Letters|January 8, 2011
1-(1-acetyl-piperidin-4-yl)-3-adamantan-1-yl-urea (AR9281) as a potent, selective, and orally available soluble epoxide hydrolase inhibitor with efficacy in rodent models of hypertension and dysglycemiaSampath-Kumar Anandan, Heather Kay Webb, Dawn Chen, et al.Pageof 3